Daniel O’Neill

911 citations

27 papers · 644 · h-index 12

Impact in

Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
Oncology
- Lung Cancer Research Studies

Papers in

Pulmonary and Respiratory Medicine 19
- Lung Cancer Treatments and Mutations 11
- Prostate Cancer Treatment and Research 8
Molecular Biology 13
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 3
- Histone Deacetylase Inhibitors Research 2

Co-authors: Luke Gaughan (9 shared papers)Craig Robson (8 shared papers)Kelly Coffey (3 shared papers)Steven Darby (2 shared papers)Dominic Jones (5 shared papers)Lynsey Rogerson (2 shared papers)Jacqueline Stockley (2 shared papers)Ian R. Logan (2 shared papers)
Journals: Cancer Research (4 papers)Molecular Cancer Therapeutics (3 papers)Drug Metabolism and Disposition (2 papers)Oncotarget (2 papers)Scientific Reports (2 papers)
Partner nations: United Kingdom United States Singapore

In The Last Decade

Daniel O’Neill

26 papers receiving 636 citations

Peers

Countries citing papers authored by Daniel O’Neill

Since Specialization

Citations

This map shows the geographic impact of Daniel O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel O’Neill more than expected).

Fields of papers citing papers by Daniel O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel O’Neill. The network helps show where Daniel O’Neill may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel O’Neill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel O’Neill Line = papers co-authored together Daniel O’Neill links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover Nucleic Acids Research ·Kelly Coffey, Lynsey Rogerson, Claudia A. Ryan-Munden, Dhuha Alkharaif, Jacqueline Stockley, Rakesh Heer, Kanagasabai Sahadevan, Daniel O’Neill, Dominic Jones, Steven Darby, Peter Staller, Alejandra Mantilla, Luke Gaughan, Craig Robson	2013	106
2	Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions Molecular Cancer Therapeutics ·Nicolas Floc’h, Matthew J. Martin, Jonathan W. Riess, Jonathan P. Orme, Anna D. Staniszewska, Ludovic Ménard, Maria Emanuela Cuomo, Daniel O’Neill, Richard A. Ward, M. Raymond V. Finlay, Darren McKerrecher, Mingshan Cheng, Daniel P. Vang, Rebekah A. Burich, James Keck, David R. Gandara, Philip C. Mack, Darren A.E. Cross	2018	87
3	Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor Journal of Biological Chemistry ·Urszula L. Burska, Victoria Harle, Kelly Coffey, Steven Darby, Hollie Ramsey, Daniel O’Neill, Ian R. Logan, Luke Gaughan, Craig Robson	2013	82
4	KDM4B is a Master Regulator of the Estrogen Receptor Signalling Cascade Nucleic Acids Research ·Luke Gaughan, Jacqueline Stockley, Kelly Coffey, Daniel O’Neill, Dominic Jones, Mark Wade, Jamie L. Wright, M. H. Moore, Sandy Tse, Lynsey Rogerson, Craig Robson	2013	71
5	Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay Scientific Reports ·Joseph Shaw, Mathew Leveridge, Charlotta Norling, Jakob Karén, Daniel Martinez Molina, Daniel O’Neill, James J. Dowling, Paul R. J. Davey, Suzanna Cowan, Michael Dabrowski, Martin J. Main, Davide Gianni	2018	53
6	Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers Nature Communications ·Tereza Vaclová, Ursula Grazini, Lewis S. C. Ward, Daniel O’Neill, Aleksandra Markovets, Xiangning Huang, Juliann Chmielecki, Ryan J. Hartmaier, Kenneth S. Thress, Paul D. Smith, J. Carl Barrett, Julian Downward, Elza C. de Bruin	2021	49
7	Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors ACS Medicinal Chemistry Letters ·Gavin W. Collie, Cheryl M. Koh, Daniel O’Neill, Christopher J. Stubbs, Puneet Khurana, Alice Eddershaw, Arjan Snijder, Fredrik Mauritzson, Louise Barlind, Ian L. Dale, Joseph Shaw, Christopher Phillips, Edward J. Hennessy, Tony Cheung, A.J. Narvaez	2019	42
8	A literature review of the evolution of British prefabricated low-rise housing Structural Survey ·Daniel O’Neill, Samantha Organ	2016	35
9	SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells Epigenetics ·Daniel O’Neill, Stuart C. Williamson, Dhuha Alkharaif, Isabella Christina Mazzaro Monteiro, Marilyn Goudreault, Luke Gaughan, Craig Robson, Anne‐Claude Gingras, Olivier Binda	2014	29
10	Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy Oncotarget ·Daniel O’Neill, Dominic Jones, Mark Wade, James Grey, Sirintra Nakjang, Wenrui Guo, David M.W. Cork, Barry R. Davies, (unknown), Craig Robson, Luke Gaughan	2015	25
11	Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non–Small Cell Lung Cancer with PIK3CA/PTEN Alterations Clinical Cancer Research ·Ursula Grazini, Aleksandra Markovets, Lucy Ireland, Daniel O’Neill, Benjamin Phillips, Man Xu, Matthias Pfeifer, Tereza Vaclová, Matthew J. Martin, Ludovic Bigot, Luc Friboulet, Ryan J. Hartmaier, Maria Emanuela Cuomo, Simon T. Barry, Paul D. Smith, Nicolas Floc’h	2024	16
12	Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier Drug Metabolism and Disposition ·Nicola Colclough, Ravindra V. Alluri, James W. Tucker, Elnaz Gozalpour, Danxi Li, Hongwen Du, Wei Li, Stephanie Harlfinger, Daniel O’Neill, Graham Sproat, Kan Chen, Yumei Yan, Dermot F. McGinnity	2023	12
13	Abstract 4451: Evaluation of the therapeutic potential of phosphine oxide pyrazole inhibitors in tumors harboring EGFR C797S mutation Cancer Research ·Nicolas Floc’h, M. Raymond V. Finlay, Ambra Bianco, Sue Bickerton, Nicola Colclough, Darren A.E. Cross, Emanuela M. Cuomo, Carine Guérot, David Hargreaves, Matthew J. Martin, Darren McKerrecher, Daniel O’Neill, Jonathan P. Orme, Amar Rahi, Paul Smith, Richard A. Ward	2019	9
14	Antitumor activity of osimertinib in NSCLC harboring EGFR exon 20 insertions. Journal of Clinical Oncology ·Jonathan W. Riess, Nicolas Floc’h, Matthew W. Martin, Jonathon P. Orme, Anna D. Staniszewska, Ludovic Ménard, Maria Emanuela Cuomo, Daniel O’Neill, Richard A. Ward, Raymond Finlay, Darren McKerrecher, Mingshan Cheng, Daniel P. Vang, Rebekah A. Tsai, Chunting Ye, James Keck, David R. Gandara, Philip C. Mack, Darren A.E. Cross	2017	5
15	Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells Oncotarget ·Ian R. Logan, Urszula L. McClurg, Dominic Jones, Daniel O’Neill, Fadhel S. Shaheen, John Lunec, Luke Gaughan, Craig Robson	2016	5
16	Abstract 3848: Preclinical profile of AZD3514: A small molecule-targeting androgen receptor function with a novel mechanism of action and the potential to treat castration-resistant prostate cancer Cancer Research ·Sarah A. Loddick, Rob H. Bradbury, Nicola Broadbent, Hayley Campbell, Luke Gaughan, Jim Growcott, Natalie Stratton, Elizabeth Mouchet, Daniel O’Neill, Al Rabow, David M. Robinson, Craig Robson, Sarah J. Ross, Fadhel S. Shaheen, Dawn Trueman, Graeme E. Walker, Stephen R. Wedge, Nigel Brooks	2012	4
17	Impact of Interindividual Differences in Plasma Fraction Unbound on the Pharmacokinetics of a Novel Syk Kinase Inhibitor in Beagle Dogs Drug Metabolism and Disposition ·Andy Pike, Barry Jones, Roshini Markandu, Daniel O’Neill	2021	3
18	Evolution of the construction of Dublin City Council’s housing, with emphasis on wall construction Structural Survey ·Daniel O’Neill, Louis Gunnigan, Peter Clarke	2015	2
19	Defining Splicing Factor Requirements for Androgen Receptor Variant Synthesis in Advanced Prostate Cancer Molecular Cancer Research ·Laura Walker, R. Scott Duncan, Beth Adamson, Hannah Kendall, Nicholas Brittain, Sara Luzzi, Dominic Jones, Lewis Chaytor, S Peel, Claire Crafter, Daniel O’Neill, Luke Gaughan	2024	2
20	Abstract 1100: Gain and loss of function genome-wide CRISPR screens identify Hippo signaling as an important driver of resistance in EGFR mutant lung cancer Cancer Research ·Matthias Pfeifer, Jonathan Brammeld, Stacey Price, Matthew J. Martin, Hannah Thorpe, Aurélie Bornot, Erica Banks, Nin Guan, Shanade Dunn, Maria Luisa Guerriero, Daniel O’Neill, James Pilling, Davide Gianni, James E. Brownell, Paul Smith, Ultan McDermott	2021	1

About Daniel O’Neill

Daniel O’Neill is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 644 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Prostate Cancer Treatment and Research (8 papers), Ubiquitin and proteasome pathways (4 papers), Cancer Genomics and Diagnostics (3 papers), Estrogen and related hormone effects (3 papers), Epigenetics and DNA Methylation (3 papers), Facilities and Workplace Management (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (233 citations), Oncology (154 citations), Molecular Biology (393 citations), Cancer Research (79 citations) and Building and Construction (33 citations). Daniel O’Neill has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Luke Gaughan, Craig Robson, Kelly Coffey, Steven Darby, Dominic Jones, Lynsey Rogerson, Jacqueline Stockley, Ian R. Logan, Mark Wade and Victoria Harle. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Drug Metabolism and Disposition, Oncotarget and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Daniel O’Neill

Impact in

Papers in i

In The Last Decade

Daniel O’Neill

Peers

Countries citing papers authored by Daniel O’Neill

Fields of papers citing papers by Daniel O’Neill

All Works

About Daniel O’Neill

Explore authors with similar magnitude of impact

Papers in